Metabolic Stack
Appetite + metabolic signaling focus
Includes:
- Retatrutide — 10 mg
- MOTS-C — 10 mg
$109.99
What's Included
Retatrutide
10mg
Retatrutide is an investigational triple hormone receptor agonist that activates receptors for glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon.
See Documentation →
MOTS-C
10mg
MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA Type-C) is a 16-amino acid peptide encoded by the mitochondrial genome.
See Documentation →Research Highlights for This Kit
Retatrutide
- A Phase 2 clinical trial published in the New England Journal of Medicine (Jastreboff et al., 2023) examined retatrutide in adults with obesity over 48 weeks. Researchers observed dose-dependent changes in body weight and metabolic parameters across treatment groups.
- A meta-analysis published in PMC (2024) analyzing three randomized controlled trials encompassing 878 patients reported that retatrutide demonstrated statistically significant effects on body weight, BMI, waist circumference, fasting plasma glucose, and HbA1c compared to placebo.
MOTS-C
- A landmark study published in Nature Communications (Reynolds et al., 2021) demonstrated that MOTS-c is an exercise-induced peptide that significantly enhanced physical performance in young, middle-aged, and old mice, with late-life treatment increasing physical capacity and healthspan markers.
- Research in Cell Metabolism (Lee et al., 2015) showed that MOTS-c targets skeletal muscle and enhances glucose metabolism, with implications for obesity, diabetes, and longevity research.
Research Use Compliance
All products in this kit are sold strictly for in vitro research, laboratory use, and scientific investigation only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease.